Delivery Order SPE2DB20D2001-SPE2DB23FM75E
Award Date 9/28/23
Potential Completion Date 10/20/23
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This is a $1,290 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 27, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization (EUA). Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through 2025....
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,290.00 under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 0.25ML MODERNA COVID-19 vaccines for individuals aged 6 months to 11 years, with a performance period through December 4, 2024. As an open competition contract, it does not have a set-aside designation....
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization. The $28,608.20 fixed-price delivery order contract has a completion date of July 9, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Moderna COVID-19 vaccines for the 6 month to 11 year old age group under the Emergency Use Authorization (EUA). The contract is a firm fixed-price delivery order with a ceiling value of $1,290.00 and a period of performance through March 13, 2025. The contract does not have a set-aside designation, indicating open competition....
- This federal contract award, with ID SPE2DX15D3018|SPE2DX24F9YQ5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $1,430.41, is for the delivery of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract, which does not have a set-aside designation, has an ultimate completion date of May 13, 2024. Amerisourcebergen Drug Corp holds a...
- This federal contract award, valued at $2,215.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $2,215.32 firm-fixed-price contract is a delivery order without a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the 0.25 mL vaccine doses to support the DLA's mission of supplying medical commodities to the...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). This is a firm-fixed-price contract with a completion date of November 13, 2023. Amerisourcebergen holds two Indefinite Delivery Contracts (IDCs) with the federal government...